Belur N Manjula

Title: Belur N Manjula: Innovator of PEGylated Hemoglobins and Albumins

Introduction

Belur N Manjula is a prominent inventor based in Cresskill, NJ. With a remarkable portfolio of 11 patents, he has made significant contributions to the field of biochemistry, particularly in the development of PEGylated hemoglobins and albumins.

Latest Patents

Among his recent innovations, the patent titled "Pegylated albumin and uses thereof" outlines the composition and methods for creating PEGylated hemoglobins and albumins. This invention introduces various forms of polyethylene glycol (PEG) conjugated to hemoglobin or albumin, including specific modifications that enhance their effectiveness. Another notable patent, "Second generation low oxygen affinity pegylated hemoglobins as oxygen-carrying plasma expanders," covers hemoglobins that have undergone chemical modifications for lowered oxygen affinity, enabling new pharmaceutical compositions and blood substitutes.

Career Highlights

During his career, Belur has collaborated with prestigious institutions such as Albert Einstein College of Medicine and La Jolla Bioengineering Institute. His work in these organizations has propelled advancements in the medical field, particularly in blood substitute technologies.

Collaborations

Belur's collaborative efforts include notable coworkers like Seetharama A Acharya and Paul K Smith, highlighting his dedication to teamwork and shared innovation in research initiatives. Such collaborations have enhanced the interdisciplinary nature of his projects, bringing together diverse expertise.

Conclusion

Belur N Manjula continues to be a driving force in the innovation of biopharmaceuticals with his inventions around PEGylated proteins. His patents serve as a testament to his commitment to finding solutions that significantly impact medical treatment and patient care. Through his work, he has established himself as a leading inventor in the realm of biochemical engineering.